Adenosine deaminase (ADA) deficiency in lymphocytes causes severe combined immunodeficiency (SCID), leading to fatal immune dysfunction in infants. Enzyme replacement therapy, like transfusing red blood cells with ADA, offers a potential treatment for this genetic disorder.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Context:
Purpose:
Summary:
Impact: